← Mechanisms of action
F8
SINGLE PROTEINHomo sapiens
Preferred name: Coagulation factor VIII ChEMBL ↗
Linked proteins
Drugs acting on this target (43)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) | Agonist | approved | Recombinant protein | F8 agonist |
| antihemophilic factor viii (Recombinant), porcine sequence (Obizur) | Agonist | approved | Recombinant protein | F8 agonist |
| antihemophilic factor viii (Recombinant), single chain (Afstyla) | Agonist | approved | Recombinant protein | F8 agonist |
| antihemophilic factor viii human (Hemofil M) | Agonist | approved | Biological | F8 agonist |
| Giroctocogene Fitelparvovec | Exogenous gene | experimental | Gene therapy | Coagulation factor VIII exogenous gene |
| antihemophilic factor viii (Recombinant) (Adynovate) | Exogenous protein | approved | Recombinant protein | Coagulation factor VIII exogenous protein |
| antihemophilic factor viii (Recombinant), porcine sequence (Obizur) | Exogenous protein | approved | Recombinant protein | Coagulation factor VIII exogenous protein |
| antihemophilic factor viii (Recombinant), single chain (Afstyla) | Exogenous protein | approved | Recombinant protein | Coagulation factor VIII exogenous protein |
| bivv001 (Advate) | Exogenous protein | experimental | Recombinant protein | Coagulation factor VIII exogenous protein |
| moroctocog-alfa | Exogenous protein | experimental | Recombinant protein | Coagulation factor VIII exogenous protein |
| turoctocog alfa | Exogenous protein | experimental | Recombinant protein | Coagulation factor VIII exogenous protein |
| drotrecogin alfa, activated (Xigris) | Inhibitor | approved | Recombinant protein | F8 inhibitor |
| emicizumab (Hemlibra) | Inhibitor | approved | mAb | F8 inhibitor |
| nnc0365-3769 a | Inhibitor | experimental | mAb | F8 inhibitor |
| ss109 | Inhibitor | experimental | Small molecule | F8 inhibitor |
| tb-402 | Inhibitor | experimental | mAb | F8 inhibitor |
| aav2/6 human factor viii | Supplementation | experimental | Gene therapy | F8 supplementation |
| aav2/8-hlp-fviii-v3 | Supplementation | experimental | Gene therapy | F8 supplementation |
| anb-010 | Supplementation | experimental | Gene therapy | F8 supplementation |
| antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl (ALTUVIIIO) | Supplementation | approved | Recombinant protein | F8 supplementation |
| antihemophilic factor viii (Recombinant) (Adynovate) | Supplementation | approved | Recombinant protein | F8 supplementation |
| antihemophilic factor viii (Recombinant), porcine sequence (Obizur) | Supplementation | approved | Recombinant protein | F8 supplementation |
| asc618 | Supplementation | experimental | Gene therapy | F8 supplementation |
| auto cd34 pbsc transduced with a lentiviral vector encoding a novel coagulation factor viii transgene | Supplementation | experimental | Cell therapy | F8 supplementation |
| auto cd34 pbsc transduced with a lentiviral vector encoding a novel coagulation factor viii transgene | Supplementation | experimental | Cell therapy | F8 supplementation |
| bay2599023 | Supplementation | experimental | Gene therapy | F8 supplementation |
| bbm 002 | Supplementation | experimental | Gene therapy | F8 supplementation |
| bbm-h803 | Supplementation | experimental | Gene therapy | F8 supplementation |
| bivv001 (Advate) | Supplementation | experimental | Recombinant protein | F8 supplementation |
| Giroctocogene Fitelparvovec | Supplementation | experimental | Gene therapy | F8 supplementation |
| gs1191 | Supplementation | experimental | Gene therapy | F8 supplementation |
| human transfer factor | Supplementation | experimental | Biological | F8 supplementation |
| moroctocog-alfa | Supplementation | experimental | Recombinant protein | F8 supplementation |
| nggt003 | Supplementation | experimental | Gene therapy | F8 supplementation |
| nnc0442-0344 | Supplementation | experimental | Recombinant protein | F8 supplementation |
| nonacog beta pegol | Supplementation | experimental | Biological | F8 supplementation |
| rurioctocog alfa pegol | Supplementation | experimental | Recombinant protein | F8 supplementation |
| sct800 | Supplementation | experimental | Recombinant protein | F8 supplementation |
| spk-8011 | Supplementation | experimental | Gene therapy | F8 supplementation |
| spk-8016 | Supplementation | experimental | Gene therapy | F8 supplementation |
| turoctocog alfa | Supplementation | experimental | Recombinant protein | F8 supplementation |
| valoctocogene roxaparvovec (Roctavian) | Supplementation | approved | Gene therapy | F8 supplementation |
| yuva-gt-f801 | Supplementation | experimental | Gene therapy | F8 supplementation |